Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-01-05

FDA Approved: LACOSAMIDE — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA granted approval for lacosamide as an Original Application for Aurobindo Pharma Limited, enabling a generic lacosamide product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lacosamide (Lacosamide)

Snippet

ORIG AP for LACOSAMIDE (LACOSAMIDE)